BATON ROUGE, La., Sept. 26 /PRNewswire-FirstCall/ -- Albemarle Corporation (NYSE: ALB), a global supplier of the active pharmaceutical ingredient Ibuprofen, will increase the price of its Ibuprofen 40 micron and Ibuprofen 70 micron products by 12 percent, and its Ibuprofen 20 micron product by 20 percent, worldwide, effective October 15, 2007, or as contracts allow.
"Albemarle proudly stands behind its quality record, which is supported through decades of outstanding FDA inspection performance at our plant in Orangeburg, South Carolina," said Brian Carter, Global Business Manager, Pharmaceutical Actives. "This price increase will allow us to continue to supply the industry with a consistent, reliable supply of what we believe is the highest quality Ibuprofen available on the market today."
Albemarle Corporation, headquartered in Richmond, Virginia, is a leading global developer, manufacturer and marketer of highly engineered specialty chemicals for petroleum and petrochemical processing; transportation and industrial products; consumer electronics; pharmaceuticals; agricultural products; and construction and packaging materials. The Company operates in three business segments, Polymer Additives, Catalysts and Fine Chemicals, and serves customers in approximately 100 countries. For more information about Albemarle, please visit http://www.albemarle.com.
ALBEMARLE is a registered trademark of Albemarle Corporation.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
|SOURCE Albemarle Corporation|
Copyright©2007 PR Newswire.
All rights reserved